&w=3840&q=100)
Lupin gets USFDA nod for generic kidney disease treatment drug Tolvaptan
Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.
The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Tolvaptan tablets of strengths 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg, Lupin said in a regulatory filing.
These are bioequivalent to Jynarque tablets in the same strengths of Otsuka Pharmaceutical Company Ltd, it added.
"Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin's Nagpur facility and will be launched soon," the company said.
Commenting on the approval, Lupin CEO Vinita Gupta said,"This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally." Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD), it said.
These tablets had an estimated annual sale of $1,467 million in the US in 2024.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
Alembic Pharma stock jumps 12% on US nod for its generic cancer drug
CHENNAI: Shares of Vadodara-based drug maker Alembic Pharmaceuticals jumped over 12% after the company received approval from the US Food and Drug Administration (USFDA) for its generic version of Doxorubicin Hydrochloride Liposome injection. This drug is used in cancer treatment and is part of a high-value and competitive segment in the US pharmaceutical market. The approval marks another important step in Alembic's efforts to expand its US generics portfolio. One of India's pioneering pharma companies, Alembic has been steadily building its presence in the US market, with more than 180 Abbreviated New Drug Applications (ANDAs) filed and over 120 already approved. This latest approval is expected to add to its revenue stream and improve market visibility, especially in the oncology segment. The company, which was previously focused mainly on the domestic market through its active pharmaceutical ingredient (API) and formulation businesses—primarily in antibiotics—has only recently begun actively expanding into international markets.
Time of India
5 hours ago
- Time of India
India a global leader in health innovation and vaccines: Jitendra
New Delhi: Underscoring India's evolution into a global health leader, Jitendra Singh, minister of state for science & technology and earth sciences and MoS in the PMO, said India was now recognised globally as a leader in healthcare innovation, pharmaceutical manufacturing and vaccine development , exporting vaccines to over 100 countries under Vaccine Maitri . "As we move forward, such partnerships will be key in shaping the future of global health from India," he said at the Times Now Doctors Day Conclave 2025, powered by Lupin. Minister of state for health and family welfare Anupriya Patel laid out the Centre's ambitious vision for India@100 and said, "We are committed to creating a resilient, inclusive and technology-driven healthcare ecosystem by 2047, as we celebrate 100 years of independence. Our vision is to ensure accessible and affordable healthcare for every citizen. The National Health Policy embodies this vision, shifting the focus from disease-specific interventions to a comprehensive and integrated approach rooted in universal health coverage. This is a paradigm shift - one that redefines how we view health and well-being, not just within India but also in alignment with global priorities." Others who spoke at the event included Punjab governor and Chandigarh administrator Gulab Chand Kataria, Tripura governor Indrasena Reddy Nallu and Andhra Pradesh health minister Satya Kumar Yadav. Kataria said since 2014, India's healthcare budget had grown from Rs 33,000 crore to Rs 99,000 crore, reflecting the govt's strong commitment to a Swasth Bharat under the leadership of PM Narenrda Modi.
Time of India
6 hours ago
- Time of India
India a global leader in health innovation and vaccines: Jitendra
NEW DELHI: Underscoring India's evolution into a global health leader, Jitendra Singh, junior minister for science & technology and earth sciences, said India was now recognised globally as a leader in healthcare innovation, pharmaceutical manufacturing and vaccine development, exporting vaccines to over 100 countries under Vaccine Maitri. "As we move forward, such partnerships will be key in shaping the future of global health from India," he said at the Times Now Doctors Day Conclave 2025, powered by Lupin. Junior minister for health and family welfare Anupriya Patel laid out the Centre's ambitious vision for India@100 and said, "We are committed to creating a resilient, inclusive and technology-driven healthcare ecosystem by 2047, as we celebrate 100 years of independence. Our vision is to ensure accessible and affordable healthcare for every citizen. The National Health Policy embodies this vision, shifting the focus from disease-specific interventions to a comprehensive and integrated approach rooted in universal health coverage. This is a paradigm shift - one that redefines how we view health and well-being, not just within India but also in alignment with global priorities." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Learn About Hotel Management Courses in Switzerland and the UK LocalPlan Search Now Undo Others who spoke at the event included Punjab governor and Chandigarh administrator Gulab Chand Kataria, Tripura governor Indrasena Reddy Nallu and Andhra Pradesh health minister Satya Kumar Yadav. Kataria said since 2014, India's healthcare budget had grown from Rs 33,000 crore to Rs 99,000 crore, reflecting the govt's strong commitment to a Swasth Bharat under the leadership of PM Narenrda Modi. Nallu spoke about transforming access to affordable healthcare by scaling telemedicine services across the nation. TNN
